Online citations, reference lists, and bibliographies.
← Back to Search

L-735,524: An Orally Bioavailable Human Immunodeficiency Virus Type 1 Protease Inhibitor.

J. Vacca, B. Dorsey, W. Schleif, R. B. Levin, S. L. Mcdaniel, P. Darke, J. Zugay, J. Quintero, O. M. Blahy, E. Roth
Published 1994 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
To date, numerous inhibitors of the human immunodeficiency virus type 1 protease have been reported, but few have been studied extensively in humans, primarily as a consequence of poor oral bioavailability in animal models. L-735,524 represents a class of human immunodeficiency virus type 1 protease inhibitors, termed hydroxyaminopentane amides, that incorporate a basic amine into the hydroxyethylene inhibitor backbone. L-735,524 is a potent inhibitor of virus replication in cell culture and inhibits the protease-mediated cleavage of the viral precursor polyproteins that results in the production of noninfectious progeny viral particles. The compound is effective against viruses resistant to reverse transcriptase inhibitors and is synergistically active when used in combination with reverse transcriptase inhibitors. Most importantly, L-735,524 exhibits good oral bioavailability and plasma pharmacokinetic profiles in two species of laboratory animals by using clinically acceptable formulations. Accordingly, the compound was selected for evaluation of safety and pharmacokinetic studies in humans.



This paper is referenced by
10.1002/9781119640929.CH4
Chemoenzymatic Synthesis of Pharmacologically Active Compounds Containing Chiral 1,2‐Amino Alcohol Moiety
Pankaj Gupta (2021)
10.1002/med.21795
1,3‐Diazepine: A privileged scaffold in medicinal chemistry
Yohan Malki (2021)
10.1016/j.rechem.2021.100174
Chiron approach and the [4 + 2] Diels-Alder cycloaddition of 2-pyrones for the synthesis of cis-(-)-aminoindan-2-ol
Arturo de la Rosa-Barrales (2021)
10.1002/0471266949.BMC260
Enzymes as Drug Targets
T. Meek (2021)
10.1016/b978-0-12-818349-6.00006-6
Principles and applications of small molecule peptidomimetics
A. Trabocchi (2020)
10.1002/ange.202008071
Regio‐ and Diastereoselective Rhodium‐Catalyzed Allylic Substitution with Unstabilized Benzyl Nucleophiles
Debasis Pal (2020)
10.3906/kim-2003-23
Synthesis and characterization of piperazine-substituted dihydrofuran derivatives viaMn(OAc) 3 mediated radical cyclizations
Sait Sari (2020)
10.3390/catal10060705
Asymmetric Ring-Opening of Epoxides Catalyzed by Metal–Salen Complexes
Anna Lidskog (2020)
10.1002/anie.202008071
Regio- and Diastereoselective Rhodium-Catalyzed Allylic Substitution with Unstabilized Benzyl Nucleophiles.
Debasis Pal (2020)
10.1016/j.tetlet.2020.152353
Concise, gram-scale synthesis of furo[2,3-b]pyridines with functional handles for chemoselective cross-coupling.
Sean N O'Byrne (2020)
10.2174/1568026619666190619115243
Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges.
Chandrashekhar Voshavar (2019)
10.1039/c9ob00544g
Dinuclear zinc synergistic catalytic asymmetric phospha-Michael/Michael cascade reaction: synthesis of 1,2,3-trisubstituted indanes bearing phosphoryl groups.
Bing-Kai Tao (2019)
10.1002/anie.201802416
A Structural View on Medicinal Chemistry Strategies against Drug Resistance.
S. Agnello (2019)
10.3906/kim-1907-16
Synthesis and characterization of unsaturated diacyl and alkyl-acyl piperazinederivatives
Sait Sari (2019)
10.2174/1568026619666190620144142
Chemical Intuition in Drug Design and Discovery.
Júlia G. B. Pedreira (2019)
10.1002/ANGE.201802416
Eine strukturelle Evaluierung medizinalchemischer Strategien gegen Wirkstoffresistenzen
Stefano Agnello (2019)
10.1002/SLCT.201801467
Organocatalytic Asymmetric Cascade Reaction of γ‐Substituted Deconjugated Butenolides with o‐Formyl‐β‐nitrostyrene
Siddharth K Deepake (2018)
10.1039/C8NJ00485D
Biocatalytic approaches towards the stereoselective synthesis of vicinal amino alcohols
Pankaj Gupta (2018)
10.1038/s41598-018-20300-9
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers
M. Secchi (2018)
10.1007/s10989-018-9673-1
Development and Evaluation of Peptide-Functionalized Gold Nanoparticles for HIV Integrase Inhibition
Lavanya Singh (2018)
10.1038/nrd.2017.219
Mechanistic enzymology in drug discovery: a fresh perspective
G. Holdgate (2018)
10.1039/C8QO00138C
Catalytic enantioselective synthesis of α-chiral azides
Pei-Gang Ding (2018)
10.1002/SLCT.201702943
An Efficient One‐Pot Synthesis of Chiral N‐Protected 3‐Substituted (Diketo)piperazines via Ugi‐4CR/De‐Boc/Cyclization Process
M. Jida (2018)
10.1002/AJOC.201800255
Nature Inspired Molecular Design: Stereoselective Synthesis of Bicyclic and Polycyclic Ethers for Potent HIV-1 Protease Inhibitors.
A. Ghosh (2018)
10.1016/J.MOLLIQ.2017.05.022
6-(2-Fluorobenzoyl)-3-(2-(4-(4-fluorophenyl)piperazin-1-yl)-2-oxoethyl)benzo[d]thiazol-2(3H)-one drug molecule structure and its interaction with atmospheric pressure plasma jet
M. Tanışlı (2017)
10.1021/acs.joc.7b00913
General Procedures for the Lithiation/Trapping of N-Boc Piperazines.
James D. Firth (2017)
10.1007/978-1-4939-0694-9_28
HIV protease inhibitor resistance
A. Wensing (2017)
10.1016/j.jmgm.2017.06.026
Investigation of the binding free energies of FDA approved drugs against subtype B and C-SA HIV PR: ONIOM approach.
Z. K. Sanusi (2017)
Sexual behaviour of HIV-diagnosed men who have sex with men in England in the era of effective antiretroviral therapy: results from the ASTRA study
M. Daskalopoulou (2017)
10.1016/B978-0-12-809712-0.00009-5
Studies on HIV-1 Protease and its Inhibitors
S. Dubey (2017)
10.1021/acs.orglett.7b02862
Switchable Chemoselectivity for Organocatalytic, Asymmetric Malononitrile Addition to ortho-Formyl Chalcones.
Sanjay Maity (2017)
10.1021/acs.orglett.7b01162
Visible-Light-Induced Tandem Radical Addition-Cyclization of Alkenyl Aldehydes Leading to Indanones and Related Compounds.
Danyang Lu (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar